Applications Published 13 August 2000
Published: 25-Mar-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Dipeptide osmosis inhibitors and the use thereof
Cytovia 1033910*Use of narrow-range ethoxylates of fatty alcohols in agricultural pesticide and adjuvant formulations
Cognis Corp 1033911*Zwitterionic fatty acid compounds for anti-inflammation
Pugliese, Peter 1033913*Compsns adapted for prolonged residence in the nasal pharynx
SmithKline Beecham 1033969*Novel formulation for use in pain management
AstraZeneca 1033970*Combined chemo-immunotherapy with liposomal drugs and cytokines
Yissum Research Development Organisation of the Hebrew University of Jerusalem 1033971*Drug delivery system with two-step targeting
Edwards, Katarina; Carlsson, Joergen; Sjoeberg, Stefan 1033972*Encapsulation method
Bioglan Therapeutics 1033973*High drug load immediate and modified release oral dosage formulations and processes for their manufacture
SmithKline Beecham 1033974*Method for producing solvent-free non-crystalline biologically active substances
Knoll 1033975*Microsphere reservoirs for controlled release application
Avecia 1033976*Pharmaceutical compsns having the shape of powders of cross-linked polymers loaded with drugs and related preparation process by supercritical fluids
Eurand International 1033977*Transdermal therapeutic system which contains a D2 agonist and which is provided for treating Parkinsonism, and a method for the production thereof
LTS Lohmann Therapie-Systeme 1033978*CYP2A enzymes and their use in therapeutic and diagnostic methods
Nicogen 1033979*Skin care compsn
Procter & Gamble 1033980*Formulations and methods for reducing toxicity of antineoplastic agents
Bionumerik Pharmaceuticals 1033981*Agents for combating Neospora species
Bayer 1033982*Cyclic amino acid derivatives as cell adhesion inhibitors
Merck 1033983*Stable ascorbic acid preparation for topical use
Avon Products 1033985*Formulations comprising dissolved paroxetine
SmithKline Beecham 1033986*Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
Janssen Pharmaceutica 1033987*Parenteral formulations comprising carbamazepine or its derivatives
Novartis 1033988*Method for reducing mast cell mediated allergic reactions
The University of Utah Research Foundation 1033989*21-hyroxy-6,19-oxidoprogesterone (21OH-6OP) and its use as a medicament for treating excess of glucocorticoids
Applied Research Systems 1033990*Mometasone furoate suspensions for nebulisation
Schering Corp 1033991*RNase L activators and antisense oligonucleotidses effective to treat RSV infections
The Cleveland Clinic Foundation; National Institutes of Health 1033992*Use of the E coli strain DSM 6601 for treating diarrhoea in veterinary medicine
Pharma-Zentrale 1033993*Methods of preparation of biogingko
Pharmanex 1033994*Insect cells or fractions as adjuvant for antigens
Protein Sciences Corp 1033995*Prevention and treatment of amyloidogenic disease
Neuralab 1033996*Method of mobilising hematopoeitic stem cells
SmithKline Beecham 1033997*Method of suppressing beta-amyloid-related changes in Alzheimer's disease
Brigham & Women's Hospital 1033998*Compsns of leukaemia inhibitory factor
Amrad Operations 1033999*Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
Hippocampe 1034000*CD154 blockade therapy for therapeutic proetin inhibitor syndrome
Biogen 1034001*Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labour
Liebovitz, Shamir 1034002*Methods for treatment of HIV or other infections using a T-cell or viral activator and anti-retroviral combination therapy
Wong, Johnson T 1034003*Recombinant Mycoplasma hyopneumoniae vaccine
Iowa State University Research Foundation 1034004*Process for the preparation of acylated cyclic 1,3-dicarbonyl compounds
Zeneca 1034159*Method for producing fatty acdi methyl ester and equipment for realising the same
Energea Umwelttechnologie 1034160*Novel compounds derivaed from menthol and use as a refreshing agent
Firmenich 1034161*9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
Roche Diagnostics 1034162*New cysteine derivatives, processes for their production, and pharmaceuticals containing them
Max-Planck-Gesellschaft zur Forderung der Wissenschaften 1034163*Substituted beta-alanine derivatives as celladhesion inhibitors
Merck & Co 1034164*Pyrazolylpyrazoles substituted by 1-methyl-5-alkylsulphonyl, 1-methyl-5-alkylsulphinyl and 1-methyl-5-akylthio, methods for preparing them and use as herbicides
Aventis CropScience 1034165*Substituted 2-phenyl-3(2H)-pyradazinones
BASF 1034166*Alpha-alkylthio substituted pyrimidine ethers ad thioethers as viral transcriptase inhibitors
Pharmacia & Upjohn 1034167*Substituted aryoloxy alkyl amino triazines
Bayer 1034168*Trisaryl-1,3,5-triazine ultraviolet light absorbers
Ciba Speciality Chemicals 1034169*2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5-HT1B and 5-HT1D)
BASF 1034170*Azaring-ether derivatives and their use as nicotinic ACH receptor modulators
Neurosearch 1034174*Substiuted phenyloxazolidinones and their uses as antibiotics
AstraZeneca 1034175*Thiophene-sulphonamide compounds
Pharmacia & Upjohn 1034176*Process for producing halogen-containinh phosphate ester
Daihachi Chemical Industry 1034177*Phosphoethanolaine conjugates of vitamin D compounds
Clarion Pharmaceuticals 1034178*Method for producing dialkylphosphinic acids
Clariant 1034179*Linker nucleoside, and production and use of the same
Aventis Research & Technologies 1034180*Crystalline amrubicin hydrochloride
Sumitomo Pharmaceuticals 1034181*Inhibition of nuclear import by backbone cyclic peptide analogues
Yissum Research Development Company of the Hebrew Univsersity of Jerusalem 1034182*Carrier-reporter bead ensembles
The University of Queensland 1034183*Pharmaceutical compns s containing the long pentraxin PTX3
Sigma-Tau Industrie Farmaceutiche Riunite 1034185*Synthetic peptides containing citrulline recognised by rheumatoid arthritis sera as tools for diagnosis and treatment
Innogenetics 1034186*(In vitro) and (in vivo) growth-promoting proteins and peptides for kidney epithelial cells
Arch Development Corp 1034187*Method of designing agonists and antagonists to IGF receptor
Comonwealth Scientific and Industrial Research Organisation 1034188*Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
Jenny Ja Antti Wihurin Rahasto 1034189*Treatment fo depression by using compounds which elevate the intracellular sodium concentration
Singer, Andrea 1034782Amide derivatives
Sumitomo Pharmaceuticals 1034783Pharmaceutical formulations containing clavulanic acid and an antibacterial agent
SmithKline Beecham 1034784Hepatitis C virus diagnostics and vaccines
Chiron Corp 1034785Type-2 chemokine binding proteins and methods of use therefor
University of Alberta 1034789HIV therapy
Schering 1034790Anti-hypoxic and anti-ischaemic drugs
Karsanov, Nikolai Vasilievich 1034791Intranasal delivery of pnemuococcal polysaccharide vaccines
Pasteur Merieux Serums et Vaccins 1034792Preventatives/remedies for glaucoma
Senju Pharmaceutical; Yoshitomi Pharmaceutical Industries 1034793A formulation of dihydroartemisinin for the control of wide spectrum of malaria
Council of Scientific and Industrial Research 1034794Conjugates of lipids and biologically active compounds
The State of Oregon acting by and through The State Board of Higher Education on bhealf of Oregon Health Sciences University 1034795MRI contrast media recognising minor environmental changes
Nihon Schering; Akaike, Toshihiro 1034796
